Company intelligence / Profile preview

China Isotope & Radiation Corporation

Ownership: Private
Development stage: Commercial

Overview

China Isotope & Radiation Corporation (CIRC) is China's largest nuclear enterprise focused on research, development, manufacturing, distribution, and service of nuclear products. It specializes in radioisotopes and radiation technologies with more than 50 production lines supplying over 70 nuclides and more than 300 products. Its offerings include radiopharmaceuticals for diagnosis and treatment as well as radioactive sources for industrial applications. CIRC operates three major manufacturing/research bases (Beijing, Chengdu, Shenzhen) with a nationwide network of radiopharmacies. It exports to over 50 countries.

Modalities: RadiopharmaceuticalRadioactive source
Industry: Biotech

Drug pipeline

1 asset

flopyramide [18F]

Unknown

Beyond the preview

Go deeper on China Isotope & Radiation Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Isotope & Radiation Corporation.

Explore the full profile